LeafNLP Demos
Back to explore

Report #2881265

Received Jan 9, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
CA
Recovered
Unknown
Vaccinated
Jan 5, 2026
Onset
Jan 5, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.1Z014047OT
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNK——

Symptoms (1)

Product storage error

Symptom narrative

No additional AE/PQC; temperature excursion for PROQUAD/ one dose was administered to a patientct; This spontaneous report was received from medical assistant and referred to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 05-Jan-2026, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (PROQUAD), 0.5 ml, subcutaneously, lot number: Z014047, expiration date: 03-Mar-2027 (anatomical location was not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (dose, lot # and expiry date were not provided). On an unknown date, the dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (PROQUAD) experienced temperature excursion from 14 to 46 Fahrenheit degrees for 1 hour and 10 minutes and 6 to 14 Fahrenheit degrees for 1 hour. There was no previous temperature excursion. On 05-Jan-2026, the dose was administered to patient (Product storage error).